Home › Hyperlipoproteinemia Type II
Hyperlipoproteinemia Type II clinical trials recruiting in the U.S.
10 studies for Hyperlipoproteinemia Type II are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
Computerized Decision Support for Identification and Management of Familial Hypercholesterolemia
Recruiting
All ages · All sexes · Updated Sep 29, 2026 · NCT06743659Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies
RecruitingPhase 3
Ages 2 to 100 · All sexes · Updated Sep 18, 2026 · NCT05682378A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Sep 2, 2026 · NCT061647302-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH)
RecruitingPhase 2
Ages 18 to 69 · All sexes · Updated Aug 7, 2026 · NCT04941599Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
RecruitingPhase 3
Ages 2 to 11 · All sexes · Updated Jul 24, 2026 · NCT06597006Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Jul 17, 2026 · NCT06451770Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
RecruitingPhase 3
Ages 6 to 11 · All sexes · Updated May 15, 2026 · NCT06597019Comparing Direct vs Indirect Methods for Cascade Screening
Recruiting
Ages 18 and older · All sexes · Updated Apr 14, 2026 · NCT05348564The ORIGIN-FH Study
Recruiting
Ages 18 and older · All sexes · Updated Mar 13, 2026 · NCT07470723Atlantic Lipid Lowering Treatment Optimization Program
Recruiting
Ages 18 to 120 · All sexes · Updated Aug 3, 2025 · NCT06439654From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.